NEWARK, Del. — According to Future Market Insights (FMI), the global critical limb ischemia treatment market is valued at USD 4.9 billion in 2026 and is projected to reach USD 9.8 billion by 2036, expanding at a 7.2% CAGR during the 2026–2036 forecast period. Clinical demand for revascularization remains a key market driver as healthcare providers address severe peripheral artery...